Kurt M Selle

This inventor holds 4 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent. Top assignee: North Carolina State University. Active years: 2018-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kurt M Selle. Retrieved from https://idiyas.com/inventor/kurt-m-selle

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 (Patent Applications = 10)

% Patents Active = 75.0

CIPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 2.3

ph-index = 2

Forward Citations = 45(Granted Patents)

Company Filing History:

4 out of 1,493

North Carolina State University

patents

Years Active: 2018-2026

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12698490 - Methods and compositions for sequences guiding Cas9 targeting (2026-08-04),

2. 11261451 - Methods for screening bacteria, archaea, algae, and yeast using CRISPR nucleic acids (2022-03-01),

3. 10787654 - Methods and compositions for sequence guiding Cas9 targeting (2020-09-29),

4. 10136649 - Methods for screening bacteria, archaea, algae, and yeast using CRISPR nucleic acids (2018-11-27),

Title: Kurt M Selle: Innovator in CRISPR Technology

Introduction

Kurt M Selle is a prominent inventor based in Raleigh, NC (US). He has made significant contributions to the field of biotechnology, particularly in the area of CRISPR technology. With a total of 4 patents, his work focuses on innovative methods for genetic screening and editing.

Latest Patents

One of Kurt's latest patents is titled "Methods for screening bacteria, archaea, algae, and yeast using CRISPR nucleic acids." This invention relates to the use of CRISPR nucleic acids to screen for essential and non-essential genes and expendable genomic islands in various microorganisms. It aims to kill these organisms, identify gene phenotypes, and screen for reduced genome size or gene deletions. Another notable patent is "Methods and compositions for sequence guiding Cas9 targeting," which is directed towards methods and compositions for genome editing and DNA targeting of proteins.

Career Highlights

Kurt M Selle is affiliated with North Carolina State University, where he continues to advance research in genetic engineering. His work has garnered attention for its potential applications in medicine and agriculture.

Collaborations

Kurt collaborates with notable researchers such as Rodolphe Barrangou and Alexandra E Briner, contributing to a dynamic research environment that fosters innovation.

Conclusion

Kurt M Selle's contributions to CRISPR technology exemplify the impact of innovative thinking in biotechnology. His patents reflect a commitment to advancing genetic research and its applications.

Profile summary based on public USPTO records.